April 17, 2025
TOPLINE: The implantation of a novel inferior vena cava (IVC) sensor demonstrated promising safety and feasibility in patients with heart failure, with its measurements showing a […]
April 16, 2025
An investigational drug, currently known as AZD0780, lowers low-density-lipoprotein cholesterol (LDL-C) to target levels in most patients whose cholesterol is still over target despite statin therapy, […]
April 16, 2025
TOPLINE: Patients with carotid tandem lesions who received intravenous thrombolysis before endovascular treatment showed similar functional outcomes and haemorrhage risks as those who received endovascular treatment […]
April 15, 2025
TOPLINE: Despite being younger and having fewer comorbidities, patients with acute myocarditis (AM) had a significantly higher risk for 30-day and long-term mortality than those with […]
April 9, 2025
CHICAGO — A transcatheter aortic valve implantation (TAVI) device developed specifically for the treatment for aortic regurgitation has met all the prespecified safety and efficacy goals, […]
April 9, 2025
TOPLINE: The overall survival after sudden cardiac arrest (SCA), including those resulting from exertional events, improved over a 9-year period among young competitive athletes in the […]
April 8, 2025
CHICAGO — The remarkable and sustained reductions in lipoprotein(a) ( Lp[a]) achieved with lepodisiran (Eli Lilly) , a novel small-interfering (si)RNA molecule, in a phase 2 […]
April 8, 2025
TOPLINE: Delayed reperfusion treatment was associated with a higher risk for both mildly to moderately and severely reduced left ventricular ejection fraction (LVEF) than timely reperfusion […]
April 7, 2025
Allowing patients with heart failure to drink as much fluid as they want had no negative effects on safety outcomes — including hospitalization and death — […]